MoneyWorks4Me

Vaishali Pharma - Quaterly Results

11 Aug 2025 Evaluate
The sales figure stood at Rs. 237.47 millions for the June 2025 quarter. The mentioned figure indicates a growth of about 31.34% as compared to Rs. 180.80 millions during the year-ago period.A slender decline of -24.60% was recorded to Rs. 12.81  millions from Rs. 16.99 millions in the corresponding previous quarter.Operating profit for the quarter ended June 2025 decreased to 22.11 millions as compared to 27.68 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 237.47 180.80 31.34 237.47 180.80 31.34 990.26 862.80 14.77
Other Income 8.43 4.24 98.82 8.43 4.24 98.82 32.05 20.34 57.57
PBIDT 22.11 27.68 -20.12 22.11 27.68 -20.12 32.95 31.71 3.91
Interest 3.32 3.79 -12.40 3.32 3.79 -12.40 15.83 17.37 -8.87
PBDT 18.79 23.89 -21.35 18.79 23.89 -21.35 17.12 14.34 19.39
Depreciation 1.42 1.19 19.33 1.42 1.19 19.33 4.87 5.08 -4.13
PBT 17.37 22.70 -23.48 17.37 22.70 -23.48 12.25 9.26 32.29
TAX 4.56 5.71 -20.14 4.56 5.71 -20.14 4.08 2.07 97.10
Deferred Tax 0.19 0.00 0.00 0.19 0.00 0.00 -0.09 -0.40 -77.50
PAT 12.81 16.99 -24.60 12.81 16.99 -24.60 8.17 7.19 13.63
Equity 260.92 120.94 115.74 260.92 120.94 115.74 260.92 107.19 143.42
PBIDTM(%) 9.31 15.31 -39.18 9.31 15.31 -39.18 3.33 3.68 -9.46
Peers